Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jain

Showing results (331-340 of 420) with videos related to

Pageof 42
Sort By:
RSC Advances|August 16, 2023
A novel series of dipeptide derivatives containing indole-3-carboxylic acid conjugates as potential antimicrobial agents: the design, solid phase peptide synthesis, <i>in vitro</i> biological evaluation, and molecular docking studySunil R Tivari, Siddhant V Kokate, Enrique Delgado-Alvarado, et al.
ACS Omega|January 1, 2024
Synthesis and Evaluation of Biological Activities for a Novel 1,2,3,4-Tetrahydroisoquinoline Conjugate with Dipeptide Derivatives: Insights from Molecular Docking and Molecular Dynamics SimulationsSunil R Tivari, Siddhant V Kokate, José L Belmonte-Vázquez, et al.
Transplantation and Cellular Therapy|March 6, 2023
Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular LymphomaNing Dong, Lucía Rubio Lopes-Garcia, David Viñal, et al.
Optics Express|June 13, 2014
First demonstration of a 2μm few-mode TDFA for mode division multiplexingY Jung, P C Shardlow, M Belal, et al.
Transplantation and Cellular Therapy|August 15, 2022
Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell TherapyDasom Lee, Aryanna I Jordan, Meghan A Menges, et al.
British Journal of Haematology|February 19, 2020
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorderMichael D Jain, Ryan Lam, Zhihui Liu, et al.
Breast Cancer Research and Treatment|June 29, 2010
DNA repair signature is associated with anthracycline response in triple negative breast cancer patientsA A Rodriguez, A Makris, M F Wu, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance proteinHiteshkumar D Jain, Chunchun Zhang, Shuo Zhou, et al.
Journal of Medicinal Chemistry|March 12, 2009
Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat modelsFelix M Rivas, James P Stables, Lauren Murphree, et al.
Journal of Medicinal Chemistry|August 21, 2018
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) InhibitorsBenjamin G Richardson, Atul D Jain, Haranatha R Potteti, et al.
Pageof 42

Showing results (331-340 of 420) with videos related to

Sort By:
Pageof 42
RSC Advances|August 16, 2023
A novel series of dipeptide derivatives containing indole-3-carboxylic acid conjugates as potential antimicrobial agents: the design, solid phase peptide synthesis, <i>in vitro</i> biological evaluation, and molecular docking studySunil R Tivari, Siddhant V Kokate, Enrique Delgado-Alvarado, et al.
ACS Omega|January 1, 2024
Synthesis and Evaluation of Biological Activities for a Novel 1,2,3,4-Tetrahydroisoquinoline Conjugate with Dipeptide Derivatives: Insights from Molecular Docking and Molecular Dynamics SimulationsSunil R Tivari, Siddhant V Kokate, José L Belmonte-Vázquez, et al.
Transplantation and Cellular Therapy|March 6, 2023
Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular LymphomaNing Dong, Lucía Rubio Lopes-Garcia, David Viñal, et al.
Optics Express|June 13, 2014
First demonstration of a 2μm few-mode TDFA for mode division multiplexingY Jung, P C Shardlow, M Belal, et al.
Transplantation and Cellular Therapy|August 15, 2022
Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell TherapyDasom Lee, Aryanna I Jordan, Meghan A Menges, et al.
British Journal of Haematology|February 19, 2020
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorderMichael D Jain, Ryan Lam, Zhihui Liu, et al.
Breast Cancer Research and Treatment|June 29, 2010
DNA repair signature is associated with anthracycline response in triple negative breast cancer patientsA A Rodriguez, A Makris, M F Wu, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance proteinHiteshkumar D Jain, Chunchun Zhang, Shuo Zhou, et al.
Journal of Medicinal Chemistry|March 12, 2009
Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat modelsFelix M Rivas, James P Stables, Lauren Murphree, et al.
Journal of Medicinal Chemistry|August 21, 2018
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) InhibitorsBenjamin G Richardson, Atul D Jain, Haranatha R Potteti, et al.
Pageof 42